Additionally, in Belo Horizonte, several mutations in BRCA1 (c.68_69delAG, c.5266dupC, c.181T > G, c.4034delA, c.5123 C > A) and BRCA2 (c.5946delT, c.8537_8538delAG, 4936_4939delGAAA) were assessed in women with ovarian cancer; none of the germline mutations were observed [22]. Here, BRCA2 is linked to ovarian carcinoma.